Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析

◆英語タイトル:Mithra Pharmaceuticals SA (MITRA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH220680FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mithra Pharmaceuticals SA (Mithra) develops and manufactures over the counter products for women’s health and other applications. The company offers various drug products such as donesta, estelle, tibelia, myring, and zoreline. Its products are used in the treatment of contraception and fertility, gynecological infections, menopause and osteoporosis; and cancers. Mithra offers its products in polymeric forms, hormonal tablets, and sterile injectable products. The company offers services such as drug development and supporting services. It offers its products under various brands such as PeriNesta, Tibelia, Estelle, and Donesta. The company offers its products through a network of distributors in Belgium, France, Germany, Luxemburg, and Brazil. Mithra is headquartered in Liege, Belgium.

Mithra Pharmaceuticals SA Key Recent Developments

Mar 31,2021: tranScrip is proud to be associated with a unique new oestrogen which has received its first product approvals
Mar 09,2021: Mithra Reports Full Year 2020 Financial Results
Mar 09,2021: Mithra Reports Full Year 2020 Financial Results
Mar 04,2021: Mithra to Host Webcast for 2020 Financial Results on 9 March 2021

This comprehensive SWOT profile of Mithra Pharmaceuticals SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mithra Pharmaceuticals SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mithra Pharmaceuticals SA – Key Information
Mithra Pharmaceuticals SA – Overview
Mithra Pharmaceuticals SA – Key Employees
Mithra Pharmaceuticals SA – Key Employee Biographies
Mithra Pharmaceuticals SA – Key Operational Heads
Mithra Pharmaceuticals SA – Major Products and Services
Mithra Pharmaceuticals SA – History
Mithra Pharmaceuticals SA – Company Statement
Mithra Pharmaceuticals SA – Locations And Subsidiaries
Mithra Pharmaceuticals SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mithra Pharmaceuticals SA – Business Description
Mithra Pharmaceuticals SA – Corporate Strategy
Mithra Pharmaceuticals SA – SWOT Analysis
SWOT Analysis – Overview
Mithra Pharmaceuticals SA – Strengths
Mithra Pharmaceuticals SA – Weaknesses
Mithra Pharmaceuticals SA – Opportunities
Mithra Pharmaceuticals SA – Threats
Mithra Pharmaceuticals SA – Key Competitors

Section 3 – Company Financial Performance Charts

Mithra Pharmaceuticals SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mithra Pharmaceuticals SA, Key Information
Mithra Pharmaceuticals SA, Key Ratios
Mithra Pharmaceuticals SA, Share Data
Mithra Pharmaceuticals SA, Major Products and Services
Mithra Pharmaceuticals SA, History
Mithra Pharmaceuticals SA, Key Employees
Mithra Pharmaceuticals SA, Key Employee Biographies
Mithra Pharmaceuticals SA, Key Operational Heads
Mithra Pharmaceuticals SA, Other Locations
Mithra Pharmaceuticals SA, Subsidiaries
Mithra Pharmaceuticals SA, Key Competitors
Mithra Pharmaceuticals SA, SWOT Analysis
Mithra Pharmaceuticals SA, Ratios based on current share price
Mithra Pharmaceuticals SA, Annual Ratios
Mithra Pharmaceuticals SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abeona Therapeutics Inc (ABEO):医療機器:M&Aディール及び事業提携情報
    Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associ …
  • Piramal Glass Pvt Ltd:企業の戦略・SWOT・財務情報
    Piramal Glass Pvt Ltd - Strategy, SWOT and Corporate Finance Report Summary Piramal Glass Pvt Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shanghai Desano Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Desano Pharmaceutical Co Ltd (Desano) is a drug manufacturing company that manufactures, develops, and markets generic APIs. The company’s products include generic APIs of anti-retroviral, oncology and anti-malarial products. It also provides APIs and FPPs. Desano's API manufacturin …
  • Amtrust Financial Services, Inc.:企業のM&A・事業提携・投資動向
    Amtrust Financial Services, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amtrust Financial Services, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Immunodiagnostic Systems Holdings plc (IDH):医療機器:M&Aディール及び事業提携情報
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Grinners Catering (Australia) Pty Ltd:企業の戦略・SWOT・財務分析
    Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • PZU SA:企業の戦略・SWOT・財務情報
    PZU SA - Strategy, SWOT and Corporate Finance Report Summary PZU SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Lee Memorial Health System:企業の戦略的SWOT分析
    Lee Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Korn/Ferry International:企業の戦略・SWOT・財務情報
    Korn/Ferry International - Strategy, SWOT and Corporate Finance Report Summary Korn/Ferry International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • GlycoMimetics Inc (GLYC):製薬・医療:M&Aディール及び事業提携情報
    Summary GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that research, develops and commercializes small molecule drugs. The company’s products comprise rivipansel (GMI-1070), under phase III clinical trial is an anti-inflammatory compound to treat vaso-occlusive crisis o …
  • China International Water & Electric Corp:企業の戦略的SWOT分析
    China International Water & Electric Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Islandsbanki hf.:企業の戦略・SWOT・財務分析
    Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report Summary Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Gazprom Neft (SIBN):企業の財務・戦略的SWOT分析
    Gazprom Neft (SIBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Teleflex Inc (TFX):医療機器:M&Aディール及び事業提携情報
    Summary Teleflex Inc (Teleflex) designs, develops, manufactures, and distributes disposable medical devices for use in critical care and surgery. Its major products include circuits, masks and bags, endotracheal tubes, pain pumps, supraglottic airways, catheters, adaptor and connectors. The company’ …
  • Prometheus Energy Group Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Prometheus Energy Group Inc (Prometheus) is an oil and gas company that supplies liquefied natural gas. The company offers services such as LNG conversion solutions, LNG storage and supply, turnkey fuel solutions, logistics and distribution, and storage, re-gas and field service. It offers t …
  • Providence Service Corporation:戦略・SWOT・企業財務分析
    Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • BC Technical Inc:医療機器:M&Aディール及び事業提携情報
    Summary BC Technical Inc (BC Technical), a subsidiary of Alpha Source Inc is a medical device company that provides molecular imaging solutions. The company offers spare parts for new and refurbished nuclear medicine equipments for gamma cameras and BC backup server. It provides PET, PET/CT, NM, SPE …
  • BlackPearl Resources Inc (PXX):石油・ガス:M&Aディール及び事業提携情報
    Summary BlackPearl Resources Inc (BlackPearl), formerly Pearl Exploration and Production Ltd, is an oil and gas company that explores, develops and produces heavy oil and oil sands assets in western Canada. The company's properties include Blackrod property, Onion Lake property and Mooney property i …
  • Peyto Exploration & Development Corp (PEY):企業の財務・戦略的SWOT分析
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆